PDPH | Test of sig | p | ||
---|---|---|---|---|
No (n = 201) | Yes (n = 84) | |||
Age (years) | ||||
Mean ± SD | 34.8 ± 11.3 | 28.3 ± 11.5 | U = 5367.50 * | < 0.001 * |
Median (Min. – Max.) | 33 (12 – 75) | 26 (13 – 69) | ||
Gender | ||||
Male | 51 (25.4%) | 9 (10.7%) | x2=7.659 * | 0.006 * |
Female | 150 (74.6%) | 75 (89.3%) | ||
BMI (kg/m2) | ||||
Mean ± SD | 36.6 ± 44.4 | 26.2 ± 3.9 | U = 2506.50 * | < 0.001 * |
Median (Min. – Max.) | 33.6 (23.6 – 657) | 24.7 (21– 38.5) | ||
Diagnosis | ||||
IIH | 96 (47.8%) | 43 (51.2%) | x2=0.279 x2=8.207 * x2=6.530 * x2=0.018 x2=3.884 x2=1.267 x2=2.401 x2=0.220 x2=9.708 * | 0.597 FEp = 0.009 * 0.011 * 0.895 FEp = 0.042 * FEp = 0.558 FEp = 0.295 FEp = 1.000 FEp = 0.007 * |
Optic neuritis | 2 (1%) | 6 (7.1%) | ||
Peripheral neuropathy | 24 (11.9%) | 2 (2.4%) | ||
Demyelinating disease | 63 (31.3%) | 27 (32.1%) | ||
SMA | 9 (4.6%) | 0 (0%) | ||
Autoimmune encephalitis | 3 (1.5%) | 0 (0%) | ||
CNS infection | 0 (0%) | 1 (1.2%) | ||
Dementia | 4 (2%) | 1 (1.2%) | ||
CVT | 0 (0%) | 4 (4.8%) | ||
Pre-LP headache | ||||
No | 188 (93.5%) | 24 (28.6%) | x2=131.210 * | < 0.001 * |
Yes | 13 (6.5%) | 60 (71.4%) | ||
History of previous PDPH | ||||
No | 196 (97.5%) | 65 (77.4%) | x2=31.133 * | < 0.001 * |
Yes | 5 (2.5%) | 19 (22.6%) | ||
LP Position | ||||
Left lateral | 165 (82.1%) | 76 (90.5%) | x2=3.192 | 0.074 |
Sitting | 36 (17.9%) | 8 (9.5%) | ||
CSF protein | ||||
Mean ± SD | 311 ± 125.8 | 262.4 ± 63.8 | U = 6743.50 | 0.312 |
Median (Min. – Max.) | 299 (100 – 755) | 250 (159 – 454) | ||
CSF glucose | ||||
Mean ± SD | 4 ± 0.9 | 4 ± 0.7 | t = 0.236 | 0.814 |
Median (Min. – Max.) | 3.7 (2.6–6.4) | 3.9 (3.1 – 5.6) | ||
CSF WBCs | ||||
No | 182 (90.5%) | 75 (89.3%) | x2=0.106 | 0.744 |
Yes | 19 (9.5%) | 9 (10.7%) | ||
Mean ± SD | 3 ± 2.6 | 7.6 ± 8.9 | U = 77.50 | 0.699 |
Median (Min. – Max.) | 2 (1 – 10) | 2 (1 – 22) | ||
CSF RBCs | ||||
Mean ± SD | 14.2 ± 168.3 | 1.8 ± 2.1 | U = 1588.50* | < 0.046* |
Median (Min. – Max.) | 6 (0 – 1236) | 1 (0 – 10) | ||
LP location | ||||
L4–L5 intervertebral space level | 148 (73.6%) | 68 (81%) | x2=1.730 | 0.188 |
L3–L4 intervertebral space level | 53 (26.4%) | 16 (19%) | ||
CSF | ||||
Opening pressure | ||||
Mean ± SD | 273.3 ± 153.4 | 268.9 ± 125.9 | U = 8248.50 | 0.759 |
Median (Min. – Max.) | 200 (95 – 990) | 300 (110 – 550) | ||
Closing pressure | ||||
Mean ± SD | 175.4 ± 39.8 | 173.5 ± 41.7 | t = 0.364 | 0.714 |
Median (Min. – Max.) | 170 (90 – 300) | 170 (110 – 300) | ||
Amount (ml) | ||||
Mean ± SD | 8.1 ± 4.1 | 9.2 ± 4.6 | U = 7669.0 | 0.190 |
Median (Min. – Max.) | 10 (5 – 35) | 10 (5 – 30) | ||
Post LP fluids | ||||
No | 175 (87.1%) | 76 (90.5%) | x2=0.659 | 0.418 |
Yes | 26 (12.9%) | 8 (9.5%) | ||
Number of LP attempts | ||||
Mean ± SD | 1.5 ± 0.8 | 3 ± 1.4 | U = 3106.0* | < 0.001* |
Median (Min. – Max.) | 1 (1 – 6) | 3 (1 – 6) | ||
Physician | ||||
Registrar | 125 (62.1%) | 60 (71.4%) | x2=3.047 | 0.096 |
Senior registrar | 52 (25.8%) | 17 (20.2%) | ||
Assistant registrar | 8 (3.9%) | 5 (5.9%) | ||
Consultant | 2 (0.9%) | 2 (2.4%) |